We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$5.46B
AUM Growth
+$427M
Cap. Flow
+$67.1M
Cap. Flow %
1.23%
Top 10 Hldgs %
5.02%
Holding
2,674
New
485
Increased
1,047
Reduced
854
Closed
280

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$38.9M
2
QCOM icon
Qualcomm
QCOM
+$33.6M
3
VEEV icon
Veeva Systems
VEEV
+$22M
4
AVGO icon
Broadcom
AVGO
+$19.5M
5
WFC icon
Wells Fargo
WFC
+$19.2M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$34.9M
2
MO icon
Altria Group
MO
+$34.6M
3
ELV icon
Elevance Health
ELV
+$32M
4
COST icon
Costco
COST
+$30M
5
HUM icon
Humana
HUM
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.31%
2 Consumer Discretionary 14.82%
3 Healthcare 13.06%
4 Financials 12.98%
5 Industrials 12.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPST icon
2376
Tempest Therapeutics
TPST
$14.6M
$7K ﹤0.01%
6
-1
-14% -$1.41K
FIT
2377
DELISTED
Fitbit, Inc. Class A common stock
FIT
$7K ﹤0.01%
+1,100
New +$6.45K
SVRA icon
2378
Savara
SVRA
$1.19B
$6K ﹤0.01%
+1,400
New +$1.69K
LRMR icon
2379
Larimar Therapeutics
LRMR
$432M
$5K ﹤0.01%
+351
New +$3.35K
ANH
2380
DELISTED
Anworth Mortgage Asset Corporation
ANH
$5K ﹤0.01%
+1,344
New +$4.65K
JILL icon
2381
J. Jill
JILL
$283M
$4K ﹤0.01%
+737
New +$5.79K
MRNS
2382
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3K ﹤0.01%
+400
New +$2.25K
ASAP
2383
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$3K ﹤0.01%
+502
New +$5.56K
GNMK
2384
DELISTED
GenMark Diagnostics, Inc
GNMK
$3K ﹤0.01%
638
-14,011
-96% -$77.3K
ABUS icon
2385
Arbutus Biopharma
ABUS
$915M
$2K ﹤0.01%
+895
New +$1.45K
CYCN icon
2386
Cyclerion Therapeutics
CYCN
$16.7M
$2K ﹤0.01%
+31
New +$2.9K
AUTL
2387
Autolus Therapeutics
AUTL
$562M
$1K ﹤0.01%
+85
New +$1.11K
BMY.RT
2388
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1K ﹤0.01%
+500
New +$1.3K
ACRS icon
2389
Aclaris Therapeutics
ACRS
$869M
– –
-10,533
Closed -$11K
AEIS icon
2390
Advanced Energy
AEIS
$13B
– –
-9,524
Closed -$547K
AFYA icon
2391
Afya
AFYA
$1.27B
– –
-1,792
Closed -$46K
AGIO icon
2392
Agios Pharmaceuticals
AGIO
$1.93B
– –
-57,675
Closed -$1.87M
AGM icon
2393
Federal Agricultural Mortgage
AGM
$2.56B
– –
-3,942
Closed -$322K
AMTD
2394
AMTD IDEA Group
AMTD
$72.6M
– –
-952
Closed -$51K
AMWD
2395
DELISTED
American Woodmark
AMWD
– –
-6,856
Closed -$610K
ANSS
2396
DELISTED
Ansys
ANSS
– –
-25,716
Closed -$5.69M
APO icon
2397
Apollo Global Management
APO
$73.4B
– –
-6,685
Closed -$253K
APOG icon
2398
Apogee Enterprises
APOG
$908M
– –
-19,331
Closed -$754K
APPF icon
2399
AppFolio
APPF
$7.04B
– –
-3,400
Closed -$323K
APVO icon
2400
Aptevo Therapeutics
APVO
$5.21M
– –
0
– –
94 95
96
97 98

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q4 2019 Portfolio in Review

As of Q4 2019, Cubist Systematic Strategies held 2,674 positions worth $5.46B, up 8.5% from $5.03B the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Cubist Systematic Strategies's Q4 2019 filing shows 485 new, 1,047 increased, 854 reduced and 280 closed positions. Its largest new stake was Sun Communities: 103,036 shares worth $15.5M. The largest sale was UnitedHealth, an estimated $34.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Cubist Systematic Strategies's largest Q4 2019 buy was Sun Communities: 103,036 shares worth $15.5M.
  • Cubist Systematic Strategies added most to Oracle in Q4 2019, an estimated $38.9M increase.
  • Cubist Systematic Strategies's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $34.9M.
  • Cubist Systematic Strategies fully exited CATALENT, INC. in Q4 2019, selling an estimated $8.4M.
  • Cubist Systematic Strategies's ten largest holdings make up 5% of its $5.46B portfolio in Q4 2019.
  • Cubist Systematic Strategies opened 485 new positions and closed 280 in Q4 2019.
  • Cubist Systematic Strategies's portfolio value rose 8.5% quarter-over-quarter to $5.46B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.